Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 31, 2015 1:23 AM ET

Pharmaceuticals

Company Overview of Merck Research Laboratories

Company Overview

Merck Research Laboratories discovers and develops medicines for cancer and neurodegenerative disorders. The company was founded in 2004 and is based in Boston, Massachusetts. Merck Research Laboratories operates as a subsidiary of Merck & Co. Inc.

33 Avenue Louis Pasteur

Boston, MA 02115

United States

Founded in 2004

Phone:

617-992-2000

Key Executives for Merck Research Laboratories

President
Age: 63
Senior Vice President and Franchise Head of Immunology Respiratory & Endocrine
Age: 61
Senior Vice President and Franchise Head of Diabetes & Obesity
Senior Vice President and Head of Franchise
Age: 59
Head of Site
Age: 60
Compensation as of Fiscal Year 2015.

Merck Research Laboratories Key Developments

TESARO and Merck Collaborate for Phase I/II Breast and Ovarian Cancer Trial

TESARO, Inc. and Merck have collaborated to evaluate the combination of TESARO's niraparib plus Merck's anti-PD1 therapy, KEYTRUDA, in a Phase I/II clinical trial in patients with breast and ovarian cancers. This trial is planned to evaluate the preliminary safety and efficacy of niraparib plus KEYTRUDA in patients with triple negative breast cancer or ovarian cancer. This trial will be conducted by TESARO and Merck, through a subsidiary, and is expected to begin by the end of 2015.

Merck Research Laboratories Presents at Sachs Immuno-Oncology: BD&L and Investment Forum, May-29-2015 08:40 AM

Merck Research Laboratories Presents at Sachs Immuno-Oncology: BD&L and Investment Forum, May-29-2015 08:40 AM. Venue: Hyatt Chicago Magnificent Mile, Chicago, Illinois, United States. Speakers: Ji Li, Vice President, Business Development and Licensing.

Merck Research Laboratories Presents at ChinaBio Partnering Forum 2015, Apr-15-2015 09:30 AM

Merck Research Laboratories Presents at ChinaBio Partnering Forum 2015, Apr-15-2015 09:30 AM. Venue: Kerry Hotel, Pudong, Shanghai, China. Speakers: Yongkui Sun, Scout, Greater China, Business Development and Licensing.

Similar Private Companies By Industry

Company Name Region
Cenomed BioSciences LLC United States
Azur Pharma, Inc. United States
Graceway Pharmaceuticals, LLC United States
Sirga Advanced Biopharma, Inc. United States
PharmStar, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Merck Research Laboratories, please visit www.merck.com/mrl. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.